喘息

私は喘息です。

I have asthma.

This is a simple statement of possession of a condition.

咳がひどい。

My cough is severe.

Describes a symptom that can be associated with asthma.

息が苦しい。

I am having trouble breathing.

Describes a common symptom of asthma.

病院に行きます。

I am going to the hospital.

A general statement about seeking medical help.

先生、助けてください。

Doctor, please help me.

A plea for help in a medical situation.

薬をください。

Please give me medicine.

Requesting medication.

吸入器を使います。

I use an inhaler.

Describes a common asthma treatment tool.

大丈夫ですか？

Are you okay?

Asking about someone's well-being.

子供が喘息にかかっています。

My child has asthma.

Using the verb 'kakarimasu' (to get/catch) for an illness.

喘息の発作が心配です。

I am worried about asthma attacks.

Expressing worry about a specific aspect of the condition.

夜中に咳が出ます。

I cough at night.

Describing a common pattern of asthma symptoms.

運動すると息が切れやすいです。

I get out of breath easily when I exercise.

Linking exercise to breathlessness.

アレルギーの検査をしました。

I had an allergy test.

Connecting allergies, a common trigger, to a medical test.

この薬は喘息に効きますか？

Is this medicine effective for asthma?

Asking about the efficacy of medication for the condition.

タバコの煙は吸わないでください。

Please do not smoke cigarettes.

A direct request to avoid a known trigger.

喘息の人は注意が必要です。

People with asthma need to be careful.

Stating the need for caution for individuals with asthma.

喘息の症状は人によって異なります。

Asthma symptoms vary from person to person.

Using the particle 'wa' for topic and expressing variation.

医師は喘息の診断を下しました。

The doctor made a diagnosis of asthma.

Using the verb 'kudashimasu' (to give/make a decision) for diagnosis.

喘息の管理には、定期的な受診が不可欠です。

Regular medical check-ups are essential for managing asthma.

Using 'ni wa' for topic/context and 'fukaketsu' (essential).

寒冷な気候は喘息の引き金になることがあります。

Cold weather can be a trigger for asthma.

Using 'hikigane ni naru' (to become a trigger).

喘息患者のためのサポートグループがありますか？

Are there any support groups for asthma patients?

Using the noun suffix 'kanja' (patient) and asking about groups.

吸入ステロイドは喘息の炎症を抑えるのに役立ちます。

Inhaled steroids help to reduce inflammation in asthma.

Using 'en-shō' (inflammation) and 'osaeru' (to suppress/reduce).

喘息の治療法は近年大きく進歩しました。

Treatments for asthma have advanced significantly in recent years.

Using 'chiryo-hō' (treatment method) and 'shinpo shimashita' (advanced).

喘息と診断された場合、生活習慣の見直しが必要です。

If diagnosed with asthma, a review of lifestyle habits is necessary.

Using conditional 'baai' (in the case of) and 'mijōshi ga hitsuyō' (review is necessary).

喘息の病態生理は複雑で、多様な要因が関与しています。

The pathophysiology of asthma is complex, involving various factors.

Using 'byōtai seiri' (pathophysiology) and 'tayō na yōin ga kan'yo shite imasu' (various factors are involved).

小児喘息の早期発見と介入は、長期的な予後に大きく影響します。

Early detection and intervention for childhood asthma greatly impact the long-term prognosis.

Using 'shōni zensoku' (childhood asthma), 'sōki hakken' (early detection), 'kainyū' (intervention), and 'yo-go' (prognosis).

喘息の管理目標は、症状のコントロールとQOLの向上です。

The goals of asthma management are symptom control and improvement of QOL.

Using 'kanri mokuhyō' (management goals), 'kontorōru' (control), and 'QOL no kōjō' (improvement of QOL).

環境要因、特に大気汚染物質は、喘息の悪化に寄与することが示されています。

Environmental factors, particularly air pollutants, have been shown to contribute to asthma exacerbation.

Using 'taiki osen busshitsu' (air pollutants), 'akuka' (worsening/exacerbation), and 'katsuyo suru koto ga shimesarete imasu' (have been shown to contribute).

喘息患者は、インフルエンザワクチン接種を強く推奨されます。

Asthma patients are strongly recommended to get the influenza vaccine.

Using 'waku-chin sesshu' (vaccine inoculation) and 'tsuyoku suisen saremasu' (are strongly recommended).

気道過敏性の評価は、喘息の診断において重要な要素です。

Assessment of airway hyperresponsiveness is an important element in the diagnosis of asthma.

Using 'kidō kabinsei' (airway hyperresponsiveness) and 'hyōka' (assessment).

喘息と他の呼吸器疾患との鑑別診断は、慎重に行われるべきです。

Differential diagnosis between asthma and other respiratory diseases should be performed carefully.

Using 'kanbetsu shindan' (differential diagnosis) and 'shinchō ni okonawareru beki desu' (should be performed carefully).

喘息の病状管理における患者教育の役割は非常に大きいです。

The role of patient education in the management of asthma is very significant.

Using 'byōjō kanri' (management of illness) and 'kanja kyōiku' (patient education).

喘息の慢性的な気道炎症は、不可逆的な気道リモデリングを引き起こす可能性があります。

Chronic airway inflammation in asthma can lead to irreversible airway remodeling.

Using 'mansei teki na kidō enshō' (chronic airway inflammation) and 'fukagyaku teki na kidō rimode-ringu' (irreversible airway remodeling).

喘息の重症度分類と治療戦略の個別化は、現代の呼吸器医療における重要な課題です。

The classification of asthma severity and the individualization of treatment strategies are important challenges in modern respiratory medicine.

Using 'jūshōdo bunrui' (severity classification), 'chiryo senryaku no kobetsuka' (individualization of treatment strategies), and 'kokyu-ki iryo' (respiratory medicine).

生物学的製剤は、難治性喘息の治療に新たな可能性をもたらしています。

Biologics are bringing new possibilities to the treatment of refractory asthma.

Using 'seibutsu gakuteki seizai' (biologics) and 'nanji-sei zensoku' (refractory asthma).

喘息の診断においては、詳細な病歴聴取と身体所見の評価が不可欠です。

In the diagnosis of asthma, a detailed medical history taking and assessment of physical findings are indispensable.

Using 'shōsai na byōreki chōshu' (detailed medical history taking) and 'shintai shoken no hyōka' (assessment of physical findings).

喘息の病因論には、遺伝的素因と環境的要因の相互作用が深く関与しています。

The etiology of asthma is deeply involved with the interaction of genetic predisposition and environmental factors.

Using 'byōin-ron' (etiology), 'iden teki so-in' (genetic predisposition), and 'sōgo sayō' (interaction).

喘息の管理における長期的なアドヒアランスの維持は、治療効果を最大化する上で極めて重要です。

Maintaining long-term adherence in asthma management is extremely important for maximizing treatment efficacy.

Using 'adōharansu' (adherence) and 'saidai-ka suru ue de kiwame te jūyō' (extremely important for maximizing).

喘息の新規治療薬の開発は、予後改善に大きく貢献すると期待されています。

The development of novel therapeutic agents for asthma is expected to contribute significantly to improving prognosis.

Using 'shinki chiryōyaku' (novel therapeutic agents) and 'yogo kaizen' (prognosis improvement).

喘息の病態理解を深めることは、より効果的な個別化医療の実現に繋がります。

Deepening the understanding of asthma pathophysiology leads to the realization of more effective personalized medicine.

Using 'byōtai rikai' (understanding of pathophysiology) and 'kojika iryo' (personalized medicine).

喘息の病態生理におけるエピジェネティックな制御機構の解明は、新たな治療標的の発見に繋がる可能性があります。

Elucidating the epigenetic regulatory mechanisms in asthma pathophysiology may lead to the discovery of novel therapeutic targets.

Using 'epijenetikkuna seigyo kiko' (epigenetic regulatory mechanisms) and 'chiryō hyōteki' (therapeutic targets).

喘息の診断における気道誘発試験の感度と特異度に関する議論は、臨床現場で依然として活発です。

Discussions regarding the sensitivity and specificity of airway provocation tests in asthma diagnosis remain active in clinical practice.

Using 'kidō yūhatsu shiken' (airway provocation test), 'kando to tokii-do' (sensitivity and specificity), and 'rinshō genba' (clinical practice).

喘息における自然免疫と獲得免疫の相互作用は、疾患の重症度と治療応答性に影響を与えると考えられています。

The interplay between innate and adaptive immunity in asthma is thought to influence disease severity and treatment responsiveness.

Using 'shizen men'eki' (innate immunity), 'kakutoku men'eki' (adaptive immunity), and 'chiryō ōtōsei' (treatment responsiveness).

喘息の病態における腸内細菌叢の変化が、免疫系を介して気道過敏性に影響を及ぼすという仮説が提唱されています。

A hypothesis has been proposed that changes in the gut microbiota in asthma pathophysiology affect airway hyperresponsiveness via the immune system.

Using 'chōnai saikin-sō' (gut microbiota), 'men'eki-kei o kai-shi te' (via the immune system), and 'kasetsu ga teishō sarete imasu' (a hypothesis has been proposed).

喘息の治療における個別化アプローチは、ゲノム情報と臨床的特徴を統合することによって最適化されるべきです。

Personalized approaches in asthma treatment should be optimized by integrating genomic information and clinical characteristics.

Using 'genomu jōhō' (genomic information) and 'rinshō teki tokuchō' (clinical characteristics).

喘息の病態における気道上皮細胞の役割と、それらが放出するサイトカインの機能解析は、今後の研究の焦点となるでしょう。

The role of airway epithelial cells in asthma pathophysiology and the functional analysis of the cytokines they release will be a focus of future research.

Using 'kidō jōhi saibō' (airway epithelial cells) and 'saikain no kinō kaiseki' (functional analysis of cytokines).

喘息の診断と管理におけるバイオマーカーの探索は、より精密な層別化と治療選択に貢献すると期待されます。

The exploration of biomarkers in asthma diagnosis and management is expected to contribute to more precise stratification and treatment selection.

Using 'baiomākā' (biomarker) and 'seimitsu na sōbetsuka' (precise stratification).

喘息における免疫寛容の破綻メカニズムを理解することは、新規免疫療法開発の鍵となります。

Understanding the mechanisms of immune tolerance breakdown in asthma is key to developing novel immunotherapies.

Using 'men'eki kan'yō no hatan' (immune tolerance breakdown) and 'shinpi men'eki ryōhō kaihatsu' (novel immunotherapy development).